<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 8, 2000
PERRIGO COMPANY
--------------------------------------------------
(Exact name of registrant as specified in charter)
MICHIGAN 0-19725 38-2799573
--------------- ------------ ------------------
(State of other (Commission (I.R.S. Employer
Jurisdiction of File Number) Identification
Incorporation) Number)
515 Eastern Avenue, Allegan, Michigan 49010
------------------------------------------ -----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(616) 673-8451
--------------
<PAGE> 2
ITEM 5. Other Events
The Perrigo Company issued a press release on November 8, 2000 announcing
that in response to recommendations from the Food and Drug Administration (FDA)
it has halted shipments of all products containing the ingredient
Phenylpropanolamine (PPA), effective immediately.
The press release issued on November 8 is presented as Exhibit 99.
Certain statements in this press release are forward-looking statements
within the meaning of Section 21E of the Securities Exchange Act of 1934, as
amended and are subject to the safe harbor created thereby. Please refer to
pages 23-27 of the Company's Form 10-K for the year ended July 1, 2000 for a
discussion of certain important factors that relate to forward-looking
statements contained in this press release. Although the Company believes that
the expectations reflected in any such forward-looking statements are
reasonable, it can give no assurance that such expectations will prove to be
correct.
<PAGE> 3
ITEM 7(c). Exhibits
Exhibit 99 Press Release issued November 8, 2000
<PAGE> 4
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PERRIGO COMPANY
(Registrant)
By: /s/ Douglas R. Schrank
----------------------------------
Dated: November 8, 2000 Douglas R. Schrank
Executive Vice President and
Chief Financial Officer
<PAGE> 5
Exhibit Index
Exhibit 99 Press Release
